Strata Skin Sciences, Inc.
SSKN
$0.14
$0.014.37%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 104.15% | 43.83% | -2.34% | 46.61% | -120.69% |
| Total Depreciation and Amortization | -4.73% | -27.13% | 0.00% | -0.68% | -0.45% |
| Total Amortization of Deferred Charges | -2.50% | 2.56% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 49.20% | -335.68% | -21.98% | -93.34% | 16,492.00% |
| Change in Net Operating Assets | -216.80% | 183.75% | -480.75% | 237.31% | -145.09% |
| Cash from Operations | -273.44% | 96.70% | -252.91% | -178.24% | 332.78% |
| Capital Expenditure | 69.35% | -1,768.85% | 130.65% | 60.52% | -712.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 69.35% | -1,768.85% | 130.65% | 60.52% | -712.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -36.72% | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -36.72% | -- | -- | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -24.68% | 159.04% | -151.00% | -476.38% | -87.40% |